Every man’s testosterone declines with age on average, but the rate and severity of that decline varies enormously from one man to the next. A large genome-wide association study of nearly 9,000 men found that genetic variants near the SHBG gene were associated with substantial variation in testosterone concentration and a meaningfully increased risk of clinically low testosterone. Age sets the general downward trend, but genetics plays a real role in how steep that slope turns out to be for any individual man.
Contents
- How the SHBG Gene Determines How Much Testosterone Is Actually Usable
- Why Androgen Receptor Sensitivity Changes How Much a Testosterone Drop Actually Matters
- The Role of the CYP19A1 Gene in Converting Testosterone to Estrogen
- Genetics Sets the Trajectory, Lifestyle Still Moves the Needle
- Frequently Asked Questions
How the SHBG Gene Determines How Much Testosterone Is Actually Usable
Most testosterone in the bloodstream isn’t free to act on tissue. It’s bound to a transport protein called sex hormone-binding globulin, built from the SHBG gene, and only the small unbound fraction is biologically active. As men age, SHBG levels naturally tend to rise, which mathematically pulls down the free, usable testosterone fraction even when total testosterone hasn’t dropped nearly as much.
Genetic variants in and around the SHBG gene affect how much of this binding protein gets made and how tightly it holds onto testosterone. The genome-wide study mentioned above confirmed this locus as one of the strongest and most consistent genetic predictors of testosterone status across multiple independent cohorts. Two men with identical total testosterone readings can have meaningfully different amounts of usable, free testosterone simply based on their SHBG genetics, and that gap tends to widen with age as SHBG levels climb.
Why Androgen Receptor Sensitivity Changes How Much a Testosterone Drop Actually Matters
A second layer involves the androgen receptor itself, the docking site testosterone needs to bind before it can do anything. The AR gene contains a repeating DNA sequence called a CAG repeat, and its length affects how sensitively the receptor responds once testosterone arrives.
Shorter Repeats, More Responsive Receptors
Shorter CAG repeats are associated with a more transcriptionally active androgen receptor. The Massachusetts Male Aging Study, tracking hundreds of men over roughly eight years, found that shorter CAG repeat length was associated with a steeper age-related decline in serum androgen levels. A separate large German cohort found that men in the shortest repeat-length quartile had more than double the risk of developing clinically low testosterone over about five years of follow-up compared with other men.
Why Findings Haven’t Been Perfectly Consistent
Not every study has replicated this relationship, and a few smaller cohorts have found only a weak or non-significant link between CAG repeat length and hormone levels. The larger, longer-running studies tend to show the clearest effect, suggesting the relationship is real but modest enough that it can be obscured in smaller samples.
The Role of the CYP19A1 Gene in Converting Testosterone to Estrogen
The third piece involves aromatase, an enzyme that converts testosterone into estradiol, built from the CYP19A1 gene. This conversion happens throughout the body but ramps up substantially in fat tissue.
A study of severely obese men found that a specific CYP19A1 repeat-length variant changed how strongly body weight predicted estradiol levels, meaning some men convert a given amount of excess fat into meaningfully more estrogen than others. This matters for testosterone specifically because rising estradiol feeds back on the brain’s hormonal control center and can suppress the signal that tells the testes to keep producing testosterone in the first place. A man with a more active aromatase variant may see his testosterone drop faster than a similarly aged, similarly built man simply because more of his existing testosterone is being converted away and then further suppressing new production.
Genetics Sets the Trajectory, Lifestyle Still Moves the Needle
None of these genes make declining testosterone inevitable at a fixed pace. Body composition, sleep quality, chronic stress, and overall metabolic health all interact with this genetic backdrop, sometimes substantially. What genetics helps explain is why two men with similar habits and similar ages can end up with very different testosterone trajectories.
If your testosterone has seemed to drop faster or more noticeably than it has for other men your age, it may be worth understanding your own hormone transport, receptor sensitivity, and conversion genetics. A report covering the male hormones pathway can map where your own variants fall.
Frequently Asked Questions
Is testosterone decline with age mostly genetic?
Age is the dominant factor for the general downward trend, but research has linked genetic variation in genes like SHBG, the androgen receptor, and CYP19A1 to meaningful differences in how much and how fast testosterone availability declines between individual men.
What does the SHBG gene have to do with usable testosterone?
SHBG builds a protein that binds most circulating testosterone, leaving only a small free fraction biologically active. Genetic variation in this gene affects how much SHBG is produced and how tightly it holds testosterone, directly shaping how much is actually usable by tissue.
How does body fat affect testosterone through genetics?
The CYP19A1 gene builds aromatase, an enzyme that converts testosterone into estrogen and becomes more active in fat tissue. Genetic variants in this gene change how strongly body weight translates into estrogen production, which can in turn suppress the body’s own testosterone production.
